Fibroblasts that acquire activated phenotypes in response to the pro-fibrotic factors secreted by cancer cells, such as transforming growth factor-β (TGF-β), platelet-derived growth factor (PDGF), and fibroblast growth factor 2 (FGF2), are termed myoblasts or CAFs19. Here, FGF2 is linked to cancer.